Top Markets
#1 Islamic Coin Islamic Coin +154.29%
#2 PulseChain PulseChain +49.22%
#3 BOOK OF MEME BOOK OF MEME +30.82%
#4 RedStone RedStone +16.61%
#5 Bio Protocol Bio Protocol +16.57%
#6 edgeX edgeX +15.25%
#7 rsERG rsERG +12.23%
#8 Not in Employment, Education, or Training Not in Employment, Education, or Training +12.05%
#9 SkyAI SkyAI +11.71%
#10 Lorenzo Wrapped Bitcoin Lorenzo Wrapped Bitcoin +11.42%
Coin of the day
Islamic Coin Islamic Coin
Settings
Language
ENGLISH
Currency
USD
Theme
TMS Co., Ltd. TMS Co., Ltd.

TMS Co., Ltd.

4891
Rank in Stocks #27373
Established in 2005 and headquartered in Fuchu, Japan, TMS Co., Ltd. focuses on... Established in 2005 and headquartered in Fuchu, Japan, TMS Co., Ltd. focuses on the research, development, manufacturing, and commercialization of pharmaceuticals, quasi-drugs, drug substances, medical devices, and various medical commodities. The company's pipeline includes TMS-007, an SMTP congener demonstrating both prothrombolytic and anti-inflammatory/antioxidative activities, which has advanced through Phase 2a clinical trials for the treatment of acute ischemic stroke. Additionally, TMS-008, another SMTP congener with anti-inflammatory/antioxidative properties, is undergoing nonclinical development for addressing inflammatory complications like acute kidney injury and cancer cachexia. A third product candidate, TMS-009, is currently in preclinical development. TMS Co., Ltd. collaborates with Hokkaido University and Kanazawa University to assess the potential of its drug candidates, has a joint research agreement with Teikyo University to identify renal function biomarkers, and maintains a strategic alliance with Ji Xing Pharmaceuticals Limited.
Share Price
$0.73072946
Market Cap
$33.30M
Change (1 day)
0.00%
Change (1 year)
-31.85%
Country
JP
Trade TMS Co., Ltd. (4891)

Category

Healthcare
Number of shares outstanding for TMS Co., Ltd. (4891)
Number of shares outstanding as of August 2026: 0
According to TMS Co., Ltd. latest financial reports and stock price the company's current number of shares outstanding is 0. At the end of August 2026 the company had 0 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for TMS Co., Ltd. (4891) from 2026 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
Not enough data for the provided dates.
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M -
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 396.00M -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 483.58M -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH